Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
March 01, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug...
Bioventus Appoints Mark Singleton as Chief Financial Officer
February 28, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has appointed...
Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022
February 22, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
January 11, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue...
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 28, 2021 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present...
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
December 21, 2021 09:25 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of...
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
December 20, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug...
Bioventus to Expand Operations and Manufacturing in Memphis
November 18, 2021 08:45 ET
|
Bioventus, Inc.
MEMPHIS, Tenn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has signed a lease agreement to...
Bioventus Announces Chief Financial Officer Transition Plan
November 15, 2021 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today announced that Greg Anglum is...
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
November 09, 2021 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...